Literature DB >> 2663720

Selective suppressive effects of Trypanosoma cruzi on activated human lymphocytes.

L A Beltz1, F Kierszenbaum, M B Sztein.   

Abstract

The acute phase of Chagas' disease is accompanied by immunosuppression. To explore the underlying mechanism(s), we used an in vitro culture system in which the capacities of activated human peripheral blood mononuclear cells to express interleukin-2 receptors (IL-2R) and proliferate are markedly inhibited in the presence of Trypanosoma cruzi, the etiologic agent. The present work was designed to define the earliest time at which T. cruzi-induced suppression is manifested in terms of IL-2R expression on the cell surface and establish whether expression of other lymphocyte activation markers is also suppressed by the parasite. We found that expression of IL-2R by human peripheral blood mononuclear cells cocultured with T. cruzi and stimulated with either phytohemagglutinin or anti-CD3 (a monoclonal antibody specific for an epitope of the T cell receptor complex T3-Ti) was significantly suppressed as early as 12 h after culture initiation. Both the percentage of IL-2R+ cells and the surface density of IL-2R, measured by flow cytometry, were affected. However, expression of EA1, a human lymphocyte activation antigen known to be expressed 4 to 6 h after stimulation, was not altered by T. cruzi whether phytohemagglutinin or anti-CD3 was used. On the other hand, expression of transferrin receptors (TfR), which first occurs between 20 and 24 h after lymphocyte activation, was markedly suppressed by T. cruzi. This effect was denoted by significant reductions in both the percentage of TfR+ cells and the cell surface density of TfR whether phytohemagglutinin or anti-CD3 was used as the mitogen and was observed at all test times, i.e., at 24, 48, 72, and 96 h. Because expression of IL-2R and TfR is required for lymphoproliferation but that of the EA1 lymphocyte activation marker is apparently not, these results are consistent with the possibility that T. cruzi, at a relatively early stage during lymphocyte activation, selectively affects certain key events on which clonal expansion is dependent. Inhibition of IL-2R and TfR expression by the parasite might play a role in causing the suppressive effects associated with acute Chagas' disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2663720      PMCID: PMC313446          DOI: 10.1128/iai.57.8.2301-2305.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Isolation of Trypanosoma cruzi from the blood of infected mice by column chromatography.

Authors:  T I Mercado; K Katusha
Journal:  Prep Biochem       Date:  1979

2.  Trypanosoma cruzi: early immune responses in infected mice.

Authors:  B A Clinton; L Ortiz-Ortiz; W Garcia; T Martinez; R Capin
Journal:  Exp Parasitol       Date:  1975-06       Impact factor: 2.011

3.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

4.  Lymphoblast transformation as a measure of immune competence during experimental Chagas' disease.

Authors:  D S Cunningham; R E Kuhn
Journal:  J Parasitol       Date:  1980-06       Impact factor: 1.276

5.  On evasion of Trypanosoma cruzi from the host immune response. Lymphoproliferative responses to trypanosomal antigens during acute and chronic experimental Chagas' disease.

Authors:  F Kierszenbaum
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

6.  Isolation of Trypanosoma cruzi from blood.

Authors:  D B Budzko; F Kierszenbaum
Journal:  J Parasitol       Date:  1974-12       Impact factor: 1.276

7.  Suppressor cells present in the spleens of Trypanosoma cruzi-infected mice.

Authors:  C Ramos; I Schädtler-Siwon; L Ortiz-Ortiz
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

8.  Acquired cell-mediated immunodepression in acute Chagas' disease.

Authors:  A R Teixeira; G Teixeira; V Macêdo; A Prata
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

9.  Trypanosoma cruzi-induced suppression of the primary immune response in murine cell cultures to T-cell-dependent and -independent antigens.

Authors:  D S Cunningham; R E Kuhn
Journal:  J Parasitol       Date:  1980-02       Impact factor: 1.276

10.  Experimental Chagas' disease: kinetics of lymphocyte responses and immunological control of the transition from acute to chronic Trypanosoma cruzi infection.

Authors:  M M Hayes; F Kierszenbaum
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

View more
  10 in total

1.  Immune suppression induced by Actinobacillus actinomycetemcomitans: effects on immunoglobulin production by human B cells.

Authors:  B J Shenker; L A Vitale; D A Welham
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

2.  Gastric invasion by Trypanosoma cruzi and induction of protective mucosal immune responses.

Authors:  D F Hoft; P L Farrar; K Kratz-Owens; D Shaffer
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

3.  A Toxoplasma gondii-derived factor(s) stimulates immune downregulation: an in vitro model.

Authors:  S Haque; A Haque; L H Kasper
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

4.  Immunosuppressive effects of Prevotella intermedia on in vitro human lymphocyte activation.

Authors:  B J Shenker; L Vitale; J Slots
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

5.  Trypanosoma cruzi suppresses the expression of the p75 chain of interleukin-2 receptors on the surface of activated helper and cytotoxic human lymphocytes.

Authors:  F Kierszenbaum; M B Sztein
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

6.  Depressed T-cell proliferation associated with susceptibility to experimental Taenia crassiceps infection.

Authors:  E Sciutto; G Fragoso; M Baca; V De la Cruz; L Lemus; E Lamoyi
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

7.  Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes.

Authors:  M B Sztein; F Kierszenbaum
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

8.  Suppression by Trypanosoma brucei rhodesiense of the capacities of human T lymphocytes to express interleukin-2 receptors and proliferate after mitogenic stimulation.

Authors:  F Kierszenbaum; S Muthukkumar; L A Beltz; M B Sztein
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

9.  Does interleukin-2 restore lymphocyte responses suppressed by Trypanosoma cruzi?

Authors:  F Kierszenbaum; H Mejia Lopez; M B Sztein
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

10.  Trypanosoma cruzi induces suppression of DNA synthesis and inhibits expression of interleukin-2 receptors by stimulated human B lymphocytes.

Authors:  F Kierszenbaum; E Moretti; M B Sztein
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.